Markets:

Overview

News

Currencies

International

Treasuries

Compass Therapeutics, Inc. - Common Stock (NQ:CMPX)

5.750 -0.050 (-0.86%)

Streaming Delayed Price Updated: 1:09 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Compass Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 21, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 17, 2023

Via Benzinga

Expert Ratings for Compass Therapeutics ↗

January 27, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023 ↗

January 27, 2023

Via Benzinga

Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 24, 2023

Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in...

Via Benzinga

Dow Drops 100 Points; Verizon Issues Weak Earnings Forecast ↗

January 24, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.31% to 33,524.12 while the NASDAQ fell...

Via Benzinga

Compass Therapeutics' Combo Therapy Shows Around 38% Overall Response Rate In Pretreated Biliary Tract Cancer Patients ↗

January 20, 2023

Compass Therapeutics Inc (NASDAQ: CMPX) announced the presentation of data from a Phase 2 study of CTX-009 in combination with paclitaxel in patients with biliary tract cancers (BTC).

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022 ↗

December 16, 2022

Via Benzinga

Top Cheap Stocks: Trading Opportunities For Next Week - Sunday, Nov. 13 ↗

November 13, 2022

A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Here is a closer look at some cheap stock opportunities that...

Via Talk Markets

Executives Buy Around $9M Of 4 Penny Stocks ↗

May 18, 2022

The Nasdaq Composite index jumped by more than 300 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence...

Via Benzinga

Executives Buy Around $4M Of 5 Penny Stocks ↗

May 16, 2022

US stock futures traded slightly lower this morning on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

90 Biggest Movers From Yesterday ↗

May 13, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered...

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Down 200 Points; Dutch Bros Shares Plunge ↗

May 12, 2022

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 200 points on Thursday.

Via Benzinga

3 Stocks Under $2 Insiders Are Buying ↗

May 11, 2022

US crude oil futures traded higher on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the...

Via Benzinga

51 Biggest Movers From Yesterday ↗

April 06, 2022

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 05, 2022

Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 141.5% to $5.46 during Tuesday's regular session. Trading volume for this security as of 13:30 EST is 114.7...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2022 ↗

March 15, 2022

Upgrades For Turquoise Hill Resources Ltd (NYSE:TRQ), BMO Capital upgraded the previous rating of Underperform to Market Perform. Turquoise Hill Resources earned $0.78 in the...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 07, 2022

Gainers Nuvectis Pharma (NASDAQ:NVCT) stock moved upwards by 132.3% to $7.55 during Monday's regular session. The current volume of 17.0 million shares is 2307.5% of...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

January 31, 2022

On Monday morning, 49 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows: The largest company by market cap to hit a new 52-...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 31, 2022

Gainers Calithera Biosciences (NASDAQ:CALA) shares moved upwards by 42.8% to $0.6 during Monday's regular session. As of 12:30 EST, Calithera Biosciences's stock...

Via Benzinga

FDA Gives Green Signal To Compass Therapeutics' Mid-Stage Biliary Tract Cancer Trial In US ↗

January 20, 2022

The FDA has signed off Compass Therapeutics Inc's (NASDAQ: CMPX) IND application for CTX-009 to initiate a global Phase 2 clinical trial for CTX-009 for...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022 ↗

January 19, 2022

Upgrades For Rocket Companies Inc (NYSE:RKT), JP Mo...

Via Benzinga

Compass Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

January 07, 2022

From Compass Therapeutics, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2021 ↗

December 22, 2021

Upgrades According to Loop Capital, the prior rating for Williams-Sonoma Inc (NYSE:

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 10, 2021

Gainers Quoin Pharmaceuticals (NASDAQ:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2021 ↗

December 20, 2021

Upgrades According to Keefe, Bruyette & Woods, the prior rating for Old National Bancorp (NASDAQ:...

Via Benzinga

Compass Therapeutics to Present at the Piper Sandler 33rd Annual Healthcare Conference

November 22, 2021

From Compass Therapeutics, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021 ↗

December 15, 2021

Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE:

Via Benzinga

61 Biggest Movers From Yesterday ↗

December 02, 2021

Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) shares jumped 44.1% to close $4.61 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down...

Via Benzinga

Topics Intellectual Property

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 19, 2021

Gainers CASI Pharmaceuticals (NASDAQ:CASI

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.